Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Food and Drug Administration - August 5, 1999
Generic Name: Dronabinol
Packaging: 2.5 mg, 5 mg, and 10 mg capsules.
Sponsor: Unimed Pharmaceuticals Inc.
Provides for changes to the physician's package insert and patient's information insert per Unimed's petition to reschedule Marinol (Dronabinol) from CII to CIII according to the Drug Enforcement Administration (DEA).
990805
FD990801
SOURCE: Food and Drug Administration (FDA).
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .